Achilles Tendon Implant is sterilized via automated process.
Press Release Summary:
Pre-shaped Achilles tendon can be used in anterior cruciate ligament (ACL) repair, posterior cruciate ligament (PCL) repair, and shoulder reconstruction. It is sterilized through automated and validated BioCleanse® system, which provides low-temperature chemical sterilization to eliminate risk of donor to recipient disease transmission while retaining tissue's biomechanical integrity.
Original Press Release:
Regeneration Technologies Announces Launch of Pre-Shaped Achilles Tendon Sterilized Through the BioCleanse(R) Process
ALACHUA, Fla., Nov. 9 -- Regeneration Technologies, Inc. (RTI) (NASDAQ:RTIX), the Florida-based processor of orthopedic, cardiovascular and other biologic implants, announces the launch of the pre- shaped Achilles tendon sterilized through the BioCleanse(R) process at the fall meeting of the Arthroscopy Association of North America (AANA). The pre- shaped Achilles can be used in anterior cruciate ligament (ACL) repair, posterior cruciate ligament (PCL) repair and shoulder reconstruction.
With the launch of the pre-shaped Achilles, RTI now provides surgeons a total sterile solution for tendon and bone graft needs. Other sterilized sports medicine implants currently available include the Adjustable Length Bone-Tendon-Bone (BTB), pre-shaped BTB, tibialis tendons, semitendinosus tendons, gracilis tendons, Sterling(R) Wedge and Sterling(R) Interference Screws.
RTI's automated and validated BioCleanse system is a low-temperature chemical sterilization process that eliminates the risk of donor to recipient disease transmission while retaining the tissue's biomechanical integrity.
"We invented BioCleanse with the idea that through science we can provide surgeons and their patients with sterilized implants they know are safe," said Brian K. Hutchison, RTI chairman, president and chief executive officer. "We take our responsibilities to patients and surgeons seriously and are committed to raising the bar in science, safety and innovation."
The pre-shaped Achilles will be available through RTI's direct representatives and distributors. Information will be available at AANA, booth 314, or by contacting an RTI representative at (800) 624-7238.
About Regeneration Technologies, Inc.
RTI processes allograft and xenograft tissue into shaped implants for use in orthopedic, cardiovascular and other surgeries with a commitment to science, safety and innovation.
RTI also holds the patents on BioCleanse, the only proven tissue sterilization process validated to eliminate viruses, bacteria, fungi and spores from tissue without impacting the structural or biomechanical integrity of the tissue. The company has distributed more than half a million allograft implants sterilized with the BioCleanse process with zero incidence of infection. RTI is accredited by the American Association of Tissue Banks and was named a 2004 Technology Pioneer by the World Economic Forum.
CONTACT: Wendy Crites Wacker, APR, Corporate Communications, or Nancy Walsh, APR, Marketing Communications both of Regeneration Technologies, Inc., +1-386-418-8888
